NET PROFIT (x1000 EUR)
EMPLOYEES
GK Pharma ApS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
165
|
151
|
177 |
| Total assets |
1,289
|
1,386
|
1,408 |
| Current assets |
1,131
|
1,336
|
1,384 |
| Current liabilities |
823
|
884
|
971 |
| Equity capital |
299
|
286
|
170 |
| - share capital |
27
|
27
|
27 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
23.2%
|
20.6%
|
12.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
137.4%
|
151.1%
|
142.5% |
| Return on equity (ROE) |
55.2%
|
52.8%
|
104.1% |
| Change turnover |
0
|
0
|
-2,247 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.